Guo, Liang-Kun
Su, Yi
Zhang, Yu-Ya-Nan
Yu, Hao
Lu, Zhe
Li, Wen-Qiang
Yang, Yong-Feng
Xiao, Xiao
Yan, Hao
Lu, Tian-Lan
Li, Jun
Liao, Yun-Dan
Kang, Zhe-Wei
Wang, Li-Fang
Li, Yue
Li, Ming
Liu, Bing
Huang, Hai-Liang
Lv, Lu-Xian
Yao, Yin
Tan, Yun-Long
Breen, Gerome
Everall, Ian
Wang, Hong-Xing
Huang, Zhuo
Zhang, Dai
Yue, Wei-Hua
Clinical trials referenced in this document:
Documents that mention this clinical trial
Documents that mention this clinical trial
Funding for this research was provided by:
National Natural Science Foundation of China (81825009, 82071505, 81901358)
Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (2021-I2M-C&T-B-099, 2019-I2M-5-006)
Epilepsy Research Program of the Ontario Brain Institute (2020-NKX-XM-12)
Peking University Clinical Scientist Program (BMU2019LCKXJ012)
National Key R&D Program of China (2021YFF1201103, 2016YFC1307000)
Article History
Received: 22 December 2022
Accepted: 5 May 2023
First Online: 2 June 2023
Declarations
:
: All study protocols were approved by the Institutional Ethics Review Boards at each site and can be accessed in the Chinese Clinical Trial Registry (ExternalRef removed and ExternalRef removed). Written informed consents were obtained from all participants.
: All participants in this study have provided consent for their deidentified data to contribute to publication of the research findings.
: The authors declare that they have no competing interests.